Literature DB >> 8616989

Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples.

I R McDougall1.   

Abstract

Whole-body scintigraphy with radioiodine-131 is an important diagnostic test in the management of patients with differentiated thyroid cancer who have undergone surgical treatment. The scan can demonstrate the presence of residual thyroid or functioning metastases in lymph nodes or distant sites. However, there are a number of potential pitfalls in the interpretation of this scan that could lead to a false-positive diagnosis of cancer. The scintiscans are presented for five patients in whom uptake outside of the thyroid was not due to functioning metastases. Some of these abnormalities are physiologic, such as uptake of iodine in the gastrointestinal tract. A comprehensive list of false-positive results are tabulated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8616989     DOI: 10.1097/00003072-199510000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  13 in total

1.  Papillary thyroid cancer with metastasis to the skin.

Authors:  Roman Junik; Joanna Kłubo-Gwieździńska; Zdzislaw Zuchora; Wieslaw Zmyslowski
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

2.  Adrenal metastasis from differentiated thyroid carcinoma documented on post-therapy (131)I scan: A case based discussion.

Authors:  Rohit Ranade; Pradeep Thapa; Sandip Basu
Journal:  World J Radiol       Date:  2014-03-28

3.  Hiatal hernia uptake of iodine-131 mimicking mediastinal metastasis of papillary thyroid carcinoma.

Authors:  Mahdi Haghighatafshar; Farnaz Khajehrahimi
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

Review 4.  False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.

Authors:  Vincenzo Triggiani; Vito Angelo Giagulli; Michele Iovino; Giovanni De Pergola; Brunella Licchelli; Antonio Varraso; Franca Dicembrino; Guido Valle; Edoardo Guastamacchia
Journal:  Endocrine       Date:  2015-10-26       Impact factor: 3.633

5.  Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.

Authors:  Anjali Mishra; Lily Pal; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

6.  Retrospective imaging study on the diagnosis of pathological false positive iodine-131 scans in patients with thyroid cancer.

Authors:  Qiang Jia; Zhaowei Meng; Jian Tan; Guizhi Zhang; Yajing He; Haoran Sun; Chunshui Yu; Dong Li; Wei Zheng; Renfei Wang; Shen Wang; Xue Li; Jianping Zhang; Tianpeng Hu; N A Liu; Arun Upadhyaya
Journal:  Exp Ther Med       Date:  2015-09-11       Impact factor: 2.447

7.  Clinical Utility of SPECT/CT Imaging Post-Radioiodine Therapy: Does It Enhance Patient Management in Thyroid Cancer?

Authors:  Fahim U Hassan; Hosahalli K Mohan
Journal:  Eur Thyroid J       Date:  2015-07-31

8.  Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.

Authors:  Zhi Liu; Mingzhao Xing
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma.

Authors:  Michihiro Nakayama; Atsutaka Okizaki; Miki Sakaguchi; Shunta Ishitoya; Takahiro Uno; Junichi Sato; Koji Takahashi
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

10.  Nabothian cyst associated with high false-positive incidence of iodine-131 uptake in whole-body scans after treatment for differentiated thyroid cancer.

Authors:  Shuai Liu; Min Zhang; Yu Pan; Qian Qu; Haifei Wu; Jing Lv; Yifan Zhang
Journal:  Nucl Med Commun       Date:  2013-12       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.